Post by Sanofi
5,024,354 followers
Living with CIDP isn't a one-time diagnosis—it's an ongoing journey. And for many people, maintaining function and quality of life remains an ongoing challenge. At Sanofi, we're committed to advancing research on CIDP care, including stability, function, quality of life, and disability reduction. We're investing in research around digital biomarkers and patient-reported outcomes to better understand disease progression in CIDP. Learn more about our commitment to advancing CIDP research: http://spkl.io/60447JunY #CIDP
Video Content